Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors-Reference-Cited by-同舟云学术

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

Published:2016-02-04 Issue:5 Volume:96 Page:461-474
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Mingot-Castellano María Eva¹,Álvarez-Román María Teresa²,López-Fernández María Fernanda³,Altisent-Roca Carmen⁴,Canaro-Hirnyk Mariana Isabel⁵,Jiménez-Yuste Víctor²,Cid-Haro Ana Rosa⁶,Pérez-Garrido Rosario⁷,Sedano-Balbas Carmen⁸

Affiliation:

1. Haematology Department; Hospital Regional Universitario de Málaga; Málaga Spain

2. Thrombosis and Haemostasis Unit; Hospital Universitario La Paz.; Madrid Spain

3. Haematology Department; Complejo Hospitalario Universitario A Coruña; A Coruna Spain

4. Haemophilia Unit; Hospital Universitario Vall d'Hebron; Barcelona Spain

5. Haematology Department; Hospital Universitario Son Espases; Palma de Mallorca Spain

6. Thrombosis and Haemostasis Unit; Hospital Universitario La Fe; Valencia Spain

7. Haemophilia Unit; Hospital Universitario Virgen del Rocío; Sevilla Spain

8. Haematology Department; Hospital Universitario Marqués de Valdecilla; Cantabria Spain

Funder

Baxalta

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12730/fullpdf

Reference46 articles.

1. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors;Abshire;J Thromb Haemost,2004

2. A retrospective postlicensure survey of FEIBA efficacy and safety;DiMichele;Haemophilia,2006

3. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors;Giangrande;Haemophilia,2009

4. Efficacy of FEIBA in surgical and invasive;Negrier;Haemophilia,2004

5. Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery;Rangarajan;Haemophilia,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors;Expert Review of Hematology;2023-09-25

2. Cholecystectomy in a man with hemophilia A and inhibitor on emicizumab prophylaxis: A case report;Hematology, Transfusion and Cell Therapy;2022-12

3. Acquired Haemophilia A: A Review of What We Know;Journal of Blood Medicine;2022-11

4. Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study;European Journal of Haematology;2022-09-12

5. Management of haemophilia A with inhibitors: A regional cross‐talk;Haemophilia;2022-07-22